Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure
Karl SwedbergDepartment of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. [email protected]Faı̈ez ZannadInserm, Centre d'Investigation Clinique CIC 9501 and U961, CHU and Department of Cardiology, University of Nancy, Nancy, FranceJohn J.V. McMurrayThe British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United KingdomHenry KrumDepartment of Epidemiology and Preventive Medicine, Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, AustraliaDirk J. van VeldhuisenDepartment of Cardiology, Thorax Centre, University Medical Centre, Groningen, the NetherlandsHarry ShiPfizer (Australia) (trading as Pfizer Australia Pty Limited)John VincentPfizer Inc; New York New YorkBertram PittUniversity of Michigan School of Medicine,Ann Arbor,Michigan
2012en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba